Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

含抗腫瘤抗生素的轉移性乳癌治療方案

Información

DOI:
https://doi.org/10.1002/14651858.CD003367.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 18 octubre 2004see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Cáncer de mama

Copyright:
  1. Copyright © 2004 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Sarah J Lord

    NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, Australia

  • Davina Ghersi

    Correspondencia a: Research Policy and Translation, National Health and Medical Research Council, Canberra, Australia

    [email protected]

  • Melina Gattellari

    School of Public Health and Community Medicine, The University of New South Wales, Sydney, Australia

  • Sally Wortley

    Systematic Reviews and Healthcare Assessment, NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, Australia

  • Nicholas Wilcken

    Medical Oncology, Crown Princess Mary Cancer Centre, Westmead, Australia

  • Charlene Thornton

    School of Medicine, University of Western Sydney, Penrith, Australia

  • John Simes

    NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, Australia

Contributions of authors

DG designed the review and wrote the protocol. MG, JB, SW, CT, LB and SL collected the data for the review. SL and CT wrote the results and discussion for the review in collaboration with NW, DG and JS.

Sources of support

Internal sources

  • NHMRC Clinical Trials Centre, Australia

External sources

  • U.S. Army Medical Research Acquisition Activity, USA

Declarations of interest

None

Acknowledgements

We would like to thank Nicole Holcroft for her work in the identification of studies through the Cochrane Breast Cancer Group's specialised register. We also acknowledge the contribution made to the original concept for this review by I. Craig Henderson, Kathleen Pritchard, Martin Tattersall, Martin Stockler, Christine Brunswick, Roldano Fossati and Alessandro Liberati.

Version history

Published

Title

Stage

Authors

Version

2004 Oct 18

Antitumour antibiotic containing regimens for metastatic breast cancer

Review

Sarah J Lord, Davina Ghersi, Melina Gattellari, Sally Wortley, Nicholas Wilcken, Charlene Thornton, John Simes

https://doi.org/10.1002/14651858.CD003367.pub2

2001 Oct 23

Antitumour antibiotic containing regimens for metastatic breast cancer

Protocol

Davina Ghersi, John Simes, I C Henderson, Russell Basser, Christine Brunswick, Roldano Fossati, Alessandro Liberati, Franco Nole, Kathleen Pritchard, Martin Stockler, Martin Tattersall, Nicholas Wilcken

https://doi.org/10.1002/14651858.CD003367

Notes

This review was updated for Issue 3, 2007. A new search was conducted October 2006. One new trial was added (Fountzilas 2004) to the meta‐analysis, one new trial was exluded from the analysis (Hori 2001) and one ongoing trial was removed (Leiden Uni Centre) without results being available for inclusion.

This review was also copyeditied and a plain language summary included to replace the previous synopsis.

There were no statistically significant changes resulting from the inclusion of Fountzilas 2004 and the recommendations of the authors remain unchanged.

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.